Angelkort B. , Maurin N., Boateng K.: Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Curr Med Res Opin6:255-258, 1979.
2.
Buchanan N., Moodley GP: The effect of pentoxifylline on human erythrocyte adenosine triphosphate. IRCS Med Sci5:43, 1977.
3.
Ehrly AM: The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. J Med10:331-338, 1979.
4.
Leonhardt H. , Grigoleit HG: Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Arch Pharmacol299:197-200, 1977.
5.
Smud R., Sermukslis B., Kartin D.: Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica1:229-233, 1976.
6.
Stormer B., Kleinschmidt K., Losse D., et al: Rheological changes in blood of patients with chronic arterial occlusive disease after administration of vasoactive drugs. Curr Med Res Opin4:588-595, 1977.
7.
Weithmann KU : The influence of pentoxifylline on interactions between blood vessel wall and platelets. IRCS Med Sci8:293-294, 1980.
8.
Abramowitz HB, et al: The use of photoplethysmography in the assessment of venous insufficiency: A comparison to venous pressure measurements . Surgery86:434-441, 1979.
9.
Angelides NS , Nicolaides AN: Simultaneous isotope clearance from the muscles of the calf and thigh. Br J Surg67:220-227, 1980.
10.
Angelides NS , Nicolaides AN, Needham, T., et al: The mechanism of calf claudication: Studies of simultaneous clearance of 99mTC from the calf and thigh. Br J Surg65:204-209, 1978.
